In silico clinical trials: concepts and early adoptions
Abstract Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simul...
Saved in:
| Published in | Briefings in bioinformatics Vol. 20; no. 5; pp. 1699 - 1708 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Oxford University Press
27.09.2019
Oxford Publishing Limited (England) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abstract
Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term ‘in silico clinical trials’ refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach. |
|---|---|
| AbstractList | Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term 'in silico clinical trials' refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach.Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term 'in silico clinical trials' refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach. Abstract Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term ‘in silico clinical trials’ refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach. Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term 'in silico clinical trials' refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach. |
| Author | Russo, Giulia Viceconti, Marco Tshinanu, Flora Musuamba Pappalardo, Francesco |
| Author_xml | – sequence: 1 givenname: Francesco surname: Pappalardo fullname: Pappalardo, Francesco organization: Department of Drug Sciences, University of Catania, Catania, Italy – sequence: 2 givenname: Giulia surname: Russo fullname: Russo, Giulia organization: Department of Biomedical and Biotechnological Sciences, University of Catania, Catania 95123, Italy – sequence: 3 givenname: Flora Musuamba surname: Tshinanu fullname: Tshinanu, Flora Musuamba organization: Federal Agency for Medicines and Health Products, Brussels, Belgium and INSERM U1248, Université de Limoges, Limoges, France – sequence: 4 givenname: Marco surname: Viceconti fullname: Viceconti, Marco email: m.viceconti@sheffield.ac.uk organization: Department of Mechanical Engineering, University of Sheffield, Sheffield, UK and INSIGNEO Institute for In Silico Medicine, University of Sheffield, Sheffield, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29868882$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90E1LwzAYwPEgE-emFz-AFEQQoe5JmjSpNxm-DAZe9BzSNIWMLqlJe9i3t6PbZYin5PB7HpL_DE2cdwahGwxPGIpsUdpyUZY7oNkZusSU85QCo5P9Pecpo3k2RbMYNwAEuMAXaEoKkQshyCXiK5dE21jtE91YZ7Vqki5Y1cTnRHunTdvFRLkqMSo0u0RVvu2sd_EKndcDMteHc46-316_lh_p-vN9tXxZpzqjrEsJ56VSpqaVYUpUjKiaGaENZYAVh4JpjasCdMlMZnLQXBRAeV7kOQHFWZbN0cO4tw3-pzexk1sbtWka5YzvoyTAgAqcDx3m6O6Ebnwf3PA6SQrGiABB2aBuD6ovt6aSbbBbFXbymGQAMAIdfIzB1FLbTu0_3QVlG4lB7qvLobocqw8jjycjx61_4vsR-779z_0CpKqObQ |
| CitedBy_id | crossref_primary_10_1016_j_neurom_2023_04_472 crossref_primary_10_2174_1386207325666220105150147 crossref_primary_10_3390_ijms25179213 crossref_primary_10_7861_fhj_2021_0025 crossref_primary_10_3389_fmedt_2023_1125524 crossref_primary_10_3389_fbioe_2024_1477405 crossref_primary_10_1186_s13244_023_01599_z crossref_primary_10_1186_s12874_024_02327_x crossref_primary_10_3389_fphar_2024_1410453 crossref_primary_10_1016_j_cmpb_2023_107700 crossref_primary_10_23876_j_krcp_23_334 crossref_primary_10_1016_j_ard_2025_01_002 crossref_primary_10_1088_2516_1091_acc8a9 crossref_primary_10_1016_j_carbpol_2020_117367 crossref_primary_10_1109_JBHI_2019_2949888 crossref_primary_10_1001_jama_2024_21451 crossref_primary_10_1007_s10439_021_02787_y crossref_primary_10_1038_s41571_022_00707_0 crossref_primary_10_1016_j_shj_2022_100032 crossref_primary_10_1080_14737167_2024_2390056 crossref_primary_10_1016_j_addr_2021_02_004 crossref_primary_10_1080_2314808X_2024_2434995 crossref_primary_10_1186_s12967_024_05557_1 crossref_primary_10_3390_cancers14061525 crossref_primary_10_7554_eLife_48890 crossref_primary_10_1007_s10439_022_03078_w crossref_primary_10_1007_s43440_024_00662_w crossref_primary_10_1080_17460441_2023_2273839 crossref_primary_10_1016_j_jns_2022_120454 crossref_primary_10_1115_1_4065934 crossref_primary_10_1016_j_compbiomed_2024_108796 crossref_primary_10_1016_j_csbj_2022_03_024 crossref_primary_10_53765_20512201_29_7_226 crossref_primary_10_1186_s12859_022_04684_0 crossref_primary_10_1007_s13534_024_00423_x crossref_primary_10_1016_j_technovation_2022_102544 crossref_primary_10_1093_eurheartj_ehad270 crossref_primary_10_1002_cncy_22764 crossref_primary_10_1186_s12859_023_05374_1 crossref_primary_10_1016_j_drudis_2023_103520 crossref_primary_10_1136_jnis_2024_022000 crossref_primary_10_1177_1759720X221076211 crossref_primary_10_1002_cnm_3470 crossref_primary_10_1080_15265161_2022_2146785 crossref_primary_10_1038_s41569_024_01047_5 crossref_primary_10_1016_j_micpath_2021_105266 crossref_primary_10_3389_fmedt_2021_719380 crossref_primary_10_1038_s41541_023_00795_8 crossref_primary_10_1186_s40658_021_00429_9 crossref_primary_10_3389_fimmu_2023_1231329 crossref_primary_10_1016_j_yrtph_2023_105388 crossref_primary_10_1007_s10439_024_03636_4 crossref_primary_10_1016_j_cmpb_2022_107244 crossref_primary_10_1016_j_jaci_2023_12_031 crossref_primary_10_1038_s41467_021_23998_w crossref_primary_10_1016_j_jmbbm_2022_105259 crossref_primary_10_1038_s41598_024_65196_w crossref_primary_10_1098_rsif_2021_0583 crossref_primary_10_1007_s10439_022_03050_8 crossref_primary_10_1016_j_brain_2023_100079 crossref_primary_10_1016_j_jcyt_2024_05_016 crossref_primary_10_1007_s43441_024_00627_4 crossref_primary_10_1016_j_triboint_2023_108768 crossref_primary_10_3389_fdata_2023_1085571 crossref_primary_10_3390_app122010256 crossref_primary_10_3389_fphys_2022_1070115 crossref_primary_10_1016_j_cmpb_2023_107813 crossref_primary_10_1177_19322968211043162 crossref_primary_10_4103_IJO_IJO_197_24 crossref_primary_10_3390_medicina57060523 crossref_primary_10_1371_journal_pdig_0000082 crossref_primary_10_1007_s13311_022_01292_x crossref_primary_10_1113_JP287124 crossref_primary_10_3390_ph15050546 crossref_primary_10_1002_spy2_293 crossref_primary_10_1080_17425255_2024_2330666 crossref_primary_10_1109_ACCESS_2025_3532846 crossref_primary_10_3389_fphar_2018_00787 crossref_primary_10_1016_j_cofs_2020_04_006 crossref_primary_10_1038_s41746_025_01557_7 crossref_primary_10_1136_jitc_2020_002100 crossref_primary_10_1186_s12859_020_03872_0 crossref_primary_10_1002_cnm_3497 crossref_primary_10_3389_fdata_2020_00016 crossref_primary_10_1146_annurev_micro_060221_012134 crossref_primary_10_5493_wjem_v15_i1_94022 crossref_primary_10_1097_SLA_0000000000006365 crossref_primary_10_3389_fimmu_2023_1212981 crossref_primary_10_1098_rsfs_2019_0123 crossref_primary_10_1080_07391102_2023_2214237 crossref_primary_10_1007_s00285_022_01828_x crossref_primary_10_3390_bioengineering10060737 crossref_primary_10_3390_pr9020322 crossref_primary_10_1002_pul2_12392 crossref_primary_10_1016_j_micpro_2023_104794 crossref_primary_10_1016_j_intonc_2024_10_003 crossref_primary_10_2139_ssrn_3967218 crossref_primary_10_1080_17434440_2022_2075729 crossref_primary_10_1038_s41467_022_29534_8 crossref_primary_10_3390_jcm10235710 crossref_primary_10_1016_j_pmatsci_2025_101474 crossref_primary_10_3390_pharmaceutics16070881 crossref_primary_10_1088_2516_1091_acdc71 crossref_primary_10_1186_s12859_019_3045_5 crossref_primary_10_1115_1_4053565 crossref_primary_10_1021_acs_chemrev_0c00356 crossref_primary_10_1080_17460441_2024_2386100 crossref_primary_10_3389_fsysb_2023_1174647 crossref_primary_10_1038_s41598_020_67398_4 crossref_primary_10_1016_j_drudis_2023_103605 crossref_primary_10_1093_jalm_jfae001 crossref_primary_10_1088_2516_1091_ad04c0 crossref_primary_10_3389_fpubh_2024_1417684 crossref_primary_10_1109_OJEMB_2021_3082328 crossref_primary_10_1016_j_cmpb_2023_107728 crossref_primary_10_1016_j_cmpb_2023_107727 crossref_primary_10_3390_pharmaceutics15092274 crossref_primary_10_1002_psp4_12669 crossref_primary_10_1016_j_bioorg_2024_108111 crossref_primary_10_1007_s10439_021_02808_w crossref_primary_10_1002_mp_15963 crossref_primary_10_1007_s12015_024_10701_x crossref_primary_10_3389_fimmu_2023_1233547 crossref_primary_10_3390_biomedicines12030704 crossref_primary_10_3389_fdsfr_2022_1071620 crossref_primary_10_1002_psp4_13087 crossref_primary_10_1016_j_bbagrm_2021_194768 crossref_primary_10_2147_DDDT_S424991 crossref_primary_10_3390_pr9112087 crossref_primary_10_1021_acs_molpharmaceut_4c00758 crossref_primary_10_1016_j_bonr_2021_101154 crossref_primary_10_1038_s41540_024_00473_y crossref_primary_10_1109_TBME_2023_3286856 crossref_primary_10_1016_j_cmpb_2023_107735 crossref_primary_10_1016_j_cmpb_2022_106862 crossref_primary_10_1093_bioinformatics_btaa1026 crossref_primary_10_1109_TBME_2022_3222745 crossref_primary_10_1136_bmj_2024_081554 crossref_primary_10_1093_eurjpc_zwae254 crossref_primary_10_1109_JBHI_2022_3198145 crossref_primary_10_1002_jha2_873 crossref_primary_10_1016_j_jocs_2020_101198 crossref_primary_10_1109_OJEMB_2022_3181796 crossref_primary_10_1093_femsre_fuad004 crossref_primary_10_1016_j_compbiomed_2021_104802 crossref_primary_10_1109_JSEN_2023_3259473 crossref_primary_10_1055_s_0042_1744446 crossref_primary_10_3389_fcvm_2022_869259 crossref_primary_10_1371_journal_pcbi_1010902 crossref_primary_10_3390_pharmaceutics15020654 crossref_primary_10_1002_fft2_369 crossref_primary_10_1007_s10989_023_10565_8 crossref_primary_10_1016_j_virusres_2021_198454 |
| Cites_doi | 10.1113/jphysiol.1965.sp007745 10.1186/s12868-017-0394-8 10.1016/j.jmbbm.2008.02.005 10.1371/journal.pone.0111946 10.1136/heartjnl-2015-308044 10.1197/jamia.M1637 10.1146/annurev-bioeng-110915-114742 10.1038/s41598-018-20737-y 10.1006/taap.1994.1068 10.1126/science.1062117 10.2174/1574888X10666151001115942 10.1177/1535370217740853 10.1038/clpt.2012.236 10.1016/j.jtbi.2014.04.013 10.1016/j.humimm.2015.11.012 10.1002/0470857897.ch17 10.1152/ajpheart.01151.2011 10.1161/CIRCGENETICS.117.001804 10.1016/j.ress.2013.11.005 10.1007/978-1-4939-1115-8_19 10.1002/j.1552-4604.1994.tb02025.x 10.1152/jappl.1961.16.5.911 10.1016/j.cmpb.2005.04.005 10.1093/bioinformatics/btv172 10.1109/TCBB.2017.2733529 10.1007/978-1-4615-5959-7_28 10.1186/s12859-016-1361-6 10.1186/1471-2105-14-S6-S11 10.1056/NEJMra1512592 10.2174/138161209789105162 10.1007/s00198-016-3597-4 10.1007/BF01060893 10.1002/tera.1420490205 10.1007/978-1-60327-118-9_11 10.1080/10543406.2017.1300907 10.3389/fphys.2017.00668 10.1093/bioinformatics/btw293 10.1093/brain/awx288 10.1016/j.apsb.2016.04.004 10.1080/17425255.2017.1389897 10.1038/35074122 10.1114/1.112 10.1186/1472-6947-12-129 10.1016/S0264-410X(00)00554-5 10.1039/c0ib00092b 10.1126/science.1069492 10.1002/ddr.20415 10.1126/scitranslmed.aaa3636 10.1016/j.jbiomech.2014.12.019 10.1016/j.jocs.2010.09.002 10.1186/1471-2105-7-482 10.1186/1471-2105-6-132 10.1002/1097-0142(197707)40:1+<519::AID-CNCR2820400718>3.0.CO;2-4 10.1016/j.coi.2016.01.002 10.1371/journal.pcbi.1005724 10.1016/j.phrs.2014.08.006 10.1021/acs.jmedchem.5b01684 10.1016/j.jim.2011.11.009 10.2170/physiolsci.RP009908 10.1007/s11095-015-1699-x 10.1016/j.biotechadv.2009.10.001 10.1371/journal.pcbi.0020129 10.1038/bonekey.2015.31 10.1155/2014/902545 10.1177/0954411917702931 10.1146/annurev.genom.2.1.343 10.1258/ebm.2009.009230 10.1371/journal.pcbi.1002742 10.1016/j.jmbbm.2017.07.034 10.1016/S1359-6446(03)02600-X |
| ContentType | Journal Article |
| Copyright | The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com. The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com |
| Copyright_xml | – notice: The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 – notice: The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com. – notice: The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com |
| DBID | AAYXX CITATION NPM 7QO 7SC 8FD FR3 JQ2 K9. L7M L~C L~D P64 RC3 7X8 |
| DOI | 10.1093/bib/bby043 |
| DatabaseName | CrossRef PubMed Biotechnology Research Abstracts Computer and Information Systems Abstracts Technology Research Database Engineering Research Database ProQuest Computer Science Collection ProQuest Health & Medical Complete (Alumni) Advanced Technologies Database with Aerospace Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed Genetics Abstracts Biotechnology Research Abstracts Technology Research Database Computer and Information Systems Abstracts – Academic ProQuest Computer Science Collection Computer and Information Systems Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Advanced Technologies Database with Aerospace Biotechnology and BioEngineering Abstracts Computer and Information Systems Abstracts Professional MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Genetics Abstracts CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1477-4054 |
| EndPage | 1708 |
| ExternalDocumentID | 29868882 10_1093_bib_bby043 10.1093/bib/bby043 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -E4 .2P .I3 0R~ 1TH 23N 2WC 36B 4.4 48X 53G 5GY 5VS 6J9 70D 8VB AAGQS AAHBH AAIJN AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPQZ AAPXW AARHZ AAUQX AAVAP AAVLN ABDBF ABEJV ABEUO ABGNP ABIXL ABNKS ABPQP ABPTD ABQLI ABQTQ ABWST ABXVV ABXZS ABZBJ ACGFO ACGFS ACGOD ACIWK ACPRK ACUFI ACUHS ACUXJ ACYTK ADBBV ADEYI ADFTL ADGKP ADGZP ADHKW ADHZD ADOCK ADPDF ADQBN ADRDM ADRTK ADVEK ADYVW ADZTZ ADZXQ AECKG AEGPL AEGXH AEJOX AEKKA AEKSI AELWJ AEMDU AEMOZ AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFRAH AGINJ AGKEF AGQXC AGSYK AHMBA AHQJS AHXPO AIAGR AIJHB AJEEA AJEUX AKHUL AKVCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALTZX ALUQC ALXQX AMNDL ANAKG APIBT APWMN ARIXL AXUDD AYOIW AZVOD BAWUL BAYMD BEYMZ BHONS BQDIO BQUQU BSWAC BTQHN C1A C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EAD EAP EAS EBA EBC EBD EBR EBS EBU EE~ EJD EMB EMK EMOBN EST ESX F5P F9B FHSFR FLIZI FLUFQ FOEOM FQBLK GAUVT GJXCC GROUPED_DOAJ GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JXSIZ K1G KBUDW KOP KSI KSN M-Z M49 MK~ ML0 N9A NGC NLBLG NMDNZ NOMLY NU- O0~ O9- OAWHX ODMLO OJQWA OK1 OVD OVEED P2P PAFKI PEELM PQQKQ Q1. Q5Y QWB RD5 RPM RUSNO RW1 RXO SV3 TEORI TH9 TJP TLC TOX TR2 TUS W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ZL0 ~91 AAYXX AHGBF CITATION NPM 7QO 7SC 8FD FR3 JQ2 K9. L7M L~C L~D P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c345t-277baaef4de5a8d52af5e8ce4501a7095cc1d90cb5e3e60c789047696620a7533 |
| IEDL.DBID | TOX |
| ISSN | 1467-5463 1477-4054 |
| IngestDate | Fri Jul 11 11:52:21 EDT 2025 Mon Jun 30 08:31:31 EDT 2025 Thu Apr 03 07:06:39 EDT 2025 Tue Jul 01 03:39:26 EDT 2025 Thu Apr 24 23:07:14 EDT 2025 Wed Apr 02 06:55:43 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | computational modelling systems biomedicine regulatory agencies in silico clinical trials |
| Language | English |
| License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c345t-277baaef4de5a8d52af5e8ce4501a7095cc1d90cb5e3e60c789047696620a7533 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 |
| PMID | 29868882 |
| PQID | 2955280845 |
| PQPubID | 26846 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_2050481609 proquest_journals_2955280845 pubmed_primary_29868882 crossref_citationtrail_10_1093_bib_bby043 crossref_primary_10_1093_bib_bby043 oup_primary_10_1093_bib_bby043 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-09-27 |
| PublicationDateYYYYMMDD | 2019-09-27 |
| PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-27 day: 27 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford |
| PublicationTitle | Briefings in bioinformatics |
| PublicationTitleAlternate | Brief Bioinform |
| PublicationYear | 2019 |
| Publisher | Oxford University Press Oxford Publishing Limited (England) |
| Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
| References | Morris (2020080807562744800_bby043-B40) 2016; 102 Hunter (2020080807562744800_bby043-B12) 2002; 247 Swinney (2020080807562744800_bby043-B53) 2013; 93 Taylor (2020080807562744800_bby043-B42) 2015; 48 Pappalardo (2020080807562744800_bby043-B58) 2010; 28 Pennisi (2020080807562744800_bby043-B33) 2016; 17 Lemon (2020080807562744800_bby043-B41) 2016; 11 Singh (2020080807562744800_bby043-B64) 2016; 77 Viceconti (2020080807562744800_bby043-B18) 2016; 18 Peleg (2020080807562744800_bby043-B29) 2004; 12 Brown (2020080807562744800_bby043-B59) 2015; 7 Peters (2020080807562744800_bby043-B65) 2005; 6 ASME (2020080807562744800_bby043-B74) 2017 Kumar (2020080807562744800_bby043-B44) 2017; 18 Qasim (2020080807562744800_bby043-B37) 2016; 27 Castiglione (2020080807562744800_bby043-B73) 2014; 2014 Gullo (2020080807562744800_bby043-B26) 2015; 31 Bassingthwaighte (2020080807562744800_bby043-B10) 1997; 430 Nichol (2020080807562744800_bby043-B3) 1977; 40 Srinivasan (2020080807562744800_bby043-B9) 1994; 34 Sackmann (2020080807562744800_bby043-B31) 2006; 7 Grant (2020080807562744800_bby043-B22) 2006; 2 Yonucu (2020080807562744800_bby043-B28) 2017; 13 Cordero (2020080807562744800_bby043-B30) 2013; 14 Janes (2020080807562744800_bby043-B2) 1965; 181 Yenkie (2020080807562744800_bby043-B57) 2014; 355 Viceconti (2020080807562744800_bby043-B70) 2009; 2 Viceconti (2020080807562744800_bby043-B19) 2016 Desai (2020080807562744800_bby043-B62) 2014; 1184 Tang (2020080807562744800_bby043-B23) 2011; 3 Viceconti (2020080807562744800_bby043-B49) 2017; 231 Rappuoli (2020080807562744800_bby043-B67) 2001; 19 Stoll (2020080807562744800_bby043-B14) 2001; 294 Pappalardo (2020080807562744800_bby043-B68) 2015; 92 Finn (2020080807562744800_bby043-B56) 2016; 39 Kitano (2020080807562744800_bby043-B15) 2002; 295 Lafuente (2020080807562744800_bby043-B63) 2009; 15 Faris (2020080807562744800_bby043-B52) 2017; 376 Teutonico (2020080807562744800_bby043-B60) 2015; 32 Byczkowski (2020080807562744800_bby043-B8) 1994; 125 Zhuang (2020080807562744800_bby043-B39) 2016; 6 Alemani (2020080807562744800_bby043-B71) 2012; 376 De Vivo (2020080807562744800_bby043-B38) 2016; 59 Ravvaz (2020080807562744800_bby043-B46) 2017; 10 Lindbom (2020080807562744800_bby043-B5) 2005; 79 Rejniak (2020080807562744800_bby043-B27) 2010; 235 Popel (2020080807562744800_bby043-B11) 1998; 26 Calonaci (2020080807562744800_bby043-B20) 2012; 12 Stracuzzi (2020080807562744800_bby043-B75) 2017 Pappalardo (2020080807562744800_bby043-B25) 2016; 32 Kim (2020080807562744800_bby043-B24) 2012; 8 Davidov (2020080807562744800_bby043-B16) 2003; 8 Xu (2020080807562744800_bby043-B35) 2018; 141 Shankaran (2020080807562744800_bby043-B61) 2001; 410 Church (2020080807562744800_bby043-B45) 2018; 243 Alqahtani (2020080807562744800_bby043-B43) 2017; 13 Haddad (2020080807562744800_bby043-B50) 2017; 27 Reche (2020080807562744800_bby043-B66) 2007; 409 Haddad (2020080807562744800_bby043-B51) 2014; 123 Caiazzo (2020080807562744800_bby043-B72) 2011; 2 Cogan (2020080807562744800_bby043-B4) 1984; 247 Carusi (2020080807562744800_bby043-B69) 2012; 303 Ideker (2020080807562744800_bby043-B13) 2001; 2 Sheiner (2020080807562744800_bby043-B6) 1981; 9 Luecke (2020080807562744800_bby043-B7) 1994; 49 Viceconti (2020080807562744800_bby043-B17) 2008; 58 Andreoni (2020080807562744800_bby043-B54) 2014; 9 Lu (2020080807562744800_bby043-B48) 2017; 75 Russo (2020080807562744800_bby043-B21) 2018 Nyman (2020080807562744800_bby043-B36) 2015; 4 Zevedei-Oancea (2020080807562744800_bby043-B32) 2003; 3 Carlier (2020080807562744800_bby043-B34) 2018; 8 Passini (2020080807562744800_bby043-B47) 2017; 8 An (2020080807562744800_bby043-B55) 2011; 72 Silverman (2020080807562744800_bby043-B1) 1961; 16 |
| References_xml | – volume: 181 start-page: 59 issue: 1 year: 1965 ident: 2020080807562744800_bby043-B2 article-title: The analysis of glucose measurements by computer simulation publication-title: J Physiol doi: 10.1113/jphysiol.1965.sp007745 – volume: 18 start-page: 76. issue: 1 year: 2017 ident: 2020080807562744800_bby043-B44 article-title: In silico repurposing of antipsychotic drugs for Alzheimer's disease publication-title: BMC Neurosci doi: 10.1186/s12868-017-0394-8 – volume: 2 start-page: 120 issue: 1 year: 2009 ident: 2020080807562744800_bby043-B70 article-title: Pre-clinical validation of joint prostheses: a systematic approach publication-title: J Mech Behav Biomed Mater doi: 10.1016/j.jmbbm.2008.02.005 – volume: 9 start-page: e111946 issue: 12 year: 2014 ident: 2020080807562744800_bby043-B54 article-title: In silico models for dynamic connected cell cultures mimicking hepatocyte-endothelial cell-adipocyte interaction circle publication-title: PLoS One doi: 10.1371/journal.pone.0111946 – volume: 102 start-page: 18 issue: 1 year: 2016 ident: 2020080807562744800_bby043-B40 article-title: Computational fluid dynamics modelling in cardiovascular medicine publication-title: Heart doi: 10.1136/heartjnl-2015-308044 – volume: 12 start-page: 181 issue: 2 year: 2004 ident: 2020080807562744800_bby043-B29 article-title: Using Petri Net tools to study properties and dynamics of biological systems publication-title: J Am Med Inform Assoc doi: 10.1197/jamia.M1637 – volume: 18 start-page: 103 issue: 1 year: 2016 ident: 2020080807562744800_bby043-B18 article-title: The virtual physiological human: ten years after publication-title: Annu Rev Biomed Eng doi: 10.1146/annurev-bioeng-110915-114742 – volume: 8 start-page: 2465 issue: 1 year: 2018 ident: 2020080807562744800_bby043-B34 article-title: In silico clinical trials for pediatric orphan diseases publication-title: Sci Rep doi: 10.1038/s41598-018-20737-y – volume: 125 start-page: 228 issue: 2 year: 1994 ident: 2020080807562744800_bby043-B8 article-title: Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model publication-title: Toxicol Appl Pharmacol doi: 10.1006/taap.1994.1068 – volume: 294 start-page: 1723 issue: 5547 year: 2001 ident: 2020080807562744800_bby043-B14 article-title: A genomic-systems biology map for cardiovascular function publication-title: Science doi: 10.1126/science.1062117 – volume: 11 start-page: 666 issue: 8 year: 2016 ident: 2020080807562744800_bby043-B41 article-title: The use of mathematical modelling for improving the tissue engineering of organs and stem cell therapy publication-title: Curr Stem Cell Res Ther doi: 10.2174/1574888X10666151001115942 – volume: 243 start-page: 300 year: 2018 ident: 2020080807562744800_bby043-B45 article-title: In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials publication-title: Exp Biol Med doi: 10.1177/1535370217740853 – volume: 93 start-page: 299 issue: 4 year: 2013 ident: 2020080807562744800_bby043-B53 article-title: Phenotypic vs. target-based drug discovery for first-in-class medicines publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2012.236 – volume: 355 start-page: 219 year: 2014 ident: 2020080807562744800_bby043-B57 article-title: Optimal control for predicting customized drug dosage for superovulation stage of in vitro fertilization publication-title: J Theor Biol doi: 10.1016/j.jtbi.2014.04.013 – volume: 77 start-page: 295 issue: 3 year: 2016 ident: 2020080807562744800_bby043-B64 article-title: Major histocompatibility complex linked databases and prediction tools for designing vaccines publication-title: Hum Immunol doi: 10.1016/j.humimm.2015.11.012 – volume-title: In Silico Clinical Trials: How Computer Simulation Will Transform the Biomedical Industry year: 2016 ident: 2020080807562744800_bby043-B19 – year: 2017 ident: 2020080807562744800_bby043-B74 – volume: 247 start-page: 207 year: 2002 ident: 2020080807562744800_bby043-B12 article-title: The IUPS physiome project. International union of physiological sciences publication-title: Novartis Found Symp doi: 10.1002/0470857897.ch17 – volume: 303 start-page: H144 issue: 2 year: 2012 ident: 2020080807562744800_bby043-B69 article-title: Bridging experiments, models and simulations: an integrative approach to validation in computational cardiac electrophysiology publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.01151.2011 – volume: 10 start-page: e001804 issue: 6 year: 2017 ident: 2020080807562744800_bby043-B46 article-title: Personalized anticoagulation: optimizing Warfarin management using genetics and simulated clinical trials publication-title: Circ Cardiovasc Genet doi: 10.1161/CIRCGENETICS.117.001804 – volume: 123 start-page: 145 year: 2014 ident: 2020080807562744800_bby043-B51 article-title: Fracture prediction of cardiac lead medical devices using Bayesian networks publication-title: Reliab Eng Syst Saf doi: 10.1016/j.ress.2013.11.005 – volume: 1184 start-page: 333 year: 2014 ident: 2020080807562744800_bby043-B62 article-title: T-cell epitope prediction methods: an overview publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-1115-8_19 – volume: 34 start-page: 692 issue: 6 year: 1994 ident: 2020080807562744800_bby043-B9 article-title: Application of physiologically based pharmacokinetic models for assessing drug disposition in space publication-title: J Clin Pharmacol doi: 10.1002/j.1552-4604.1994.tb02025.x – volume: 16 start-page: 911 year: 1961 ident: 2020080807562744800_bby043-B1 article-title: Application of analogue computer to measurement of intestinal absorption rates with tracers publication-title: J Appl Physiol doi: 10.1152/jappl.1961.16.5.911 – volume: 79 start-page: 241 issue: 3 year: 2005 ident: 2020080807562744800_bby043-B5 article-title: PsN-Toolkit–a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM publication-title: Comput Methods Programs Biomed doi: 10.1016/j.cmpb.2005.04.005 – volume: 31 start-page: 2514 issue: 15 year: 2015 ident: 2020080807562744800_bby043-B26 article-title: Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv172 – year: 2018 ident: 2020080807562744800_bby043-B21 article-title: Continuous Petri Nets and microRNA analysis in melanoma publication-title: IEEE/ACM Transactions of Computational Biology and Bioinformatics doi: 10.1109/TCBB.2017.2733529 – volume: 430 start-page: 325 year: 1997 ident: 2020080807562744800_bby043-B10 article-title: Design and strategy for the Cardionome Project publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-5959-7_28 – volume: 17 start-page: 498 issue: S19 year: 2016 ident: 2020080807562744800_bby043-B33 article-title: A methodological approach for using high-level Petri Nets to model the immune system response publication-title: BMC Bioinformatics doi: 10.1186/s12859-016-1361-6 – volume: 14 start-page: S11. issue: Suppl 6 year: 2013 ident: 2020080807562744800_bby043-B30 article-title: Multi-level model for the investigation of oncoantigen-driven vaccination effect publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-14-S6-S11 – volume: 376 start-page: 1350 issue: 14 year: 2017 ident: 2020080807562744800_bby043-B52 article-title: An FDA viewpoint on unique considerations for medical-device clinical trials publication-title: N Engl J Med doi: 10.1056/NEJMra1512592 – volume: 15 start-page: 3209 issue: 28 year: 2009 ident: 2020080807562744800_bby043-B63 article-title: Prediction of MHC-peptide binding: a systematic and comprehensive overview publication-title: Curr Pharm Des doi: 10.2174/138161209789105162 – volume: 27 start-page: 2815 issue: 9 year: 2016 ident: 2020080807562744800_bby043-B37 article-title: Patient-specific finite element estimated femur strength as a predictor of the risk of hip fracture: the effect of methodological determinants publication-title: Osteoporos Int doi: 10.1007/s00198-016-3597-4 – volume: 9 start-page: 503 issue: 4 year: 1981 ident: 2020080807562744800_bby043-B6 article-title: Some suggestions for measuring predictive performance publication-title: J Pharmacokinet Biopharm doi: 10.1007/BF01060893 – volume: 49 start-page: 90 issue: 2 year: 1994 ident: 2020080807562744800_bby043-B7 article-title: A physiologically based pharmacokinetic computer model for human pregnancy publication-title: Teratology doi: 10.1002/tera.1420490205 – volume: 409 start-page: 163 year: 2007 ident: 2020080807562744800_bby043-B66 article-title: Definition of MHC supertypes through clustering of MHC peptide-binding repertoires publication-title: Methods Mol Biol doi: 10.1007/978-1-60327-118-9_11 – volume: 27 start-page: 1089 issue: 6 year: 2017 ident: 2020080807562744800_bby043-B50 article-title: Incorporation of stochastic engineering models as prior information in Bayesian medical device trials publication-title: J Biopharm Stat doi: 10.1080/10543406.2017.1300907 – volume: 247 start-page: F387 issue: 3 Pt 2 year: 1984 ident: 2020080807562744800_bby043-B4 article-title: Regulation of proximal bicarbonate reabsorption publication-title: Am J Physiol – volume: 8 start-page: 668. year: 2017 ident: 2020080807562744800_bby043-B47 article-title: Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity publication-title: Front Physiol doi: 10.3389/fphys.2017.00668 – volume: 32 start-page: 2672 issue: 17 year: 2016 ident: 2020080807562744800_bby043-B25 article-title: A computational model to predict the immune system activation by citrus-derived vaccine adjuvants publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw293 – volume: 141 start-page: 48 issue: 1 year: 2018 ident: 2020080807562744800_bby043-B35 article-title: High-dimensional therapeutic inference in the focally damaged human brain publication-title: Brain doi: 10.1093/brain/awx288 – year: 2017 ident: 2020080807562744800_bby043-B75 – volume: 6 start-page: 430 issue: 5 year: 2016 ident: 2020080807562744800_bby043-B39 article-title: PBPK modeling and simulation in drug research and development publication-title: Acta Pharm Sin B doi: 10.1016/j.apsb.2016.04.004 – volume: 13 start-page: 1147 issue: 11 year: 2017 ident: 2020080807562744800_bby043-B43 article-title: In silico ADME-Tox modeling: progress and prospects publication-title: Expert Opin Drug Metab Toxicol doi: 10.1080/17425255.2017.1389897 – volume: 410 start-page: 1107 issue: 6832 year: 2001 ident: 2020080807562744800_bby043-B61 article-title: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity publication-title: Nature doi: 10.1038/35074122 – volume: 26 start-page: 911 issue: 6 year: 1998 ident: 2020080807562744800_bby043-B11 article-title: The microcirculation physiome project publication-title: Ann Biomed Eng doi: 10.1114/1.112 – volume: 12 start-page: 129. issue: 1 year: 2012 ident: 2020080807562744800_bby043-B20 article-title: Optimal vaccination schedule search using genetic algorithm over MPI technology publication-title: BMC Med Inform Decis Mak doi: 10.1186/1472-6947-12-129 – volume: 19 start-page: 2688 issue: 17–19 year: 2001 ident: 2020080807562744800_bby043-B67 article-title: Reverse vaccinology, a genome-based approach to vaccine development publication-title: Vaccine doi: 10.1016/S0264-410X(00)00554-5 – volume: 3 start-page: 408 issue: 4 year: 2011 ident: 2020080807562744800_bby043-B23 article-title: Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling publication-title: Integr Biol doi: 10.1039/c0ib00092b – volume: 295 start-page: 1662 issue: 5560 year: 2002 ident: 2020080807562744800_bby043-B15 article-title: Systems biology: a brief overview publication-title: Science doi: 10.1126/science.1069492 – volume: 72 start-page: 187 issue: 2 year: 2011 ident: 2020080807562744800_bby043-B55 article-title: In silico augmentation of the drug development pipeline: examples from the study of Acute Inflammation publication-title: Drug Dev Res doi: 10.1002/ddr.20415 – volume: 7 start-page: 285ra61 issue: 285 year: 2015 ident: 2020080807562744800_bby043-B59 article-title: Trauma in silico: individual-specific mathematical models and virtual clinical populations publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaa3636 – volume: 48 start-page: 767 issue: 5 year: 2015 ident: 2020080807562744800_bby043-B42 article-title: Four decades of finite element analysis of orthopaedic devices: where are we now and what are the opportunities? publication-title: J Biomech doi: 10.1016/j.jbiomech.2014.12.019 – volume: 2 start-page: 9 issue: 1 year: 2011 ident: 2020080807562744800_bby043-B72 article-title: A complex automata approach for in-stent restenosis: two-dimensional multiscale modelling and simulations publication-title: J Comput Sci doi: 10.1016/j.jocs.2010.09.002 – volume: 7 start-page: 482. year: 2006 ident: 2020080807562744800_bby043-B31 article-title: Application of Petri net based analysis techniques to signal transduction pathways publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-7-482 – volume: 6 start-page: 132 year: 2005 ident: 2020080807562744800_bby043-B65 article-title: Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-6-132 – volume: 40 start-page: 519 issue: 1 Suppl year: 1977 ident: 2020080807562744800_bby043-B3 article-title: Pharmacokinetics: selectivity of action related to physicochemical properties and kinetic patterns of anticancer drugs publication-title: Cancer doi: 10.1002/1097-0142(197707)40:1+<519::AID-CNCR2820400718>3.0.CO;2-4 – volume: 39 start-page: 52 year: 2016 ident: 2020080807562744800_bby043-B56 article-title: Cancer immunoprevention publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2016.01.002 – volume: 3 start-page: 323 year: 2003 ident: 2020080807562744800_bby043-B32 article-title: Topological analysis of metabolic networks based on Petri net theory publication-title: In Silico Biol – volume: 13 start-page: e1005724 issue: 9 year: 2017 ident: 2020080807562744800_bby043-B28 article-title: Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1005724 – volume: 92 start-page: 40 year: 2015 ident: 2020080807562744800_bby043-B68 article-title: Computational modelling approaches to vaccinology publication-title: Pharmacol Res doi: 10.1016/j.phrs.2014.08.006 – volume: 59 start-page: 4035 issue: 9 year: 2016 ident: 2020080807562744800_bby043-B38 article-title: Role of molecular dynamics and related methods in drug discovery publication-title: J Med Chem doi: 10.1021/acs.jmedchem.5b01684 – volume: 376 start-page: 55 issue: 1-2 year: 2012 ident: 2020080807562744800_bby043-B71 article-title: Combining cellular automata and Lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition publication-title: J Immunol Methods doi: 10.1016/j.jim.2011.11.009 – volume: 58 start-page: 441 issue: 7 year: 2008 ident: 2020080807562744800_bby043-B17 article-title: The virtual physiological human—a European initiative for in silico human modelling publication-title: J Physiol Sci doi: 10.2170/physiolsci.RP009908 – volume: 32 start-page: 3228 issue: 10 year: 2015 ident: 2020080807562744800_bby043-B60 article-title: Generating virtual patients by multivariate and discrete re-sampling techniques publication-title: Pharm Res doi: 10.1007/s11095-015-1699-x – volume: 28 start-page: 82 issue: 1 year: 2010 ident: 2020080807562744800_bby043-B58 article-title: Vaccine protocols optimization: in silico experiences publication-title: Biotechnol Adv doi: 10.1016/j.biotechadv.2009.10.001 – volume: 2 start-page: e129 issue: 10 year: 2006 ident: 2020080807562744800_bby043-B22 article-title: Simulating properties of in vitro epithelial cell morphogenesis publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.0020129 – volume: 4 start-page: 664. year: 2015 ident: 2020080807562744800_bby043-B36 article-title: Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis publication-title: Bonekey Rep doi: 10.1038/bonekey.2015.31 – volume: 2014 start-page: 1 year: 2014 ident: 2020080807562744800_bby043-B73 article-title: Modeling biology spanning different scales: an open challenge publication-title: Biomed Res Int doi: 10.1155/2014/902545 – volume: 231 start-page: 455 issue: 5 year: 2017 ident: 2020080807562744800_bby043-B49 article-title: In silico assessment of biomedical products: the conundrum of rare but not so rare events in two case studies publication-title: Proc Inst Mech Eng H doi: 10.1177/0954411917702931 – volume: 2 start-page: 343 year: 2001 ident: 2020080807562744800_bby043-B13 article-title: A new approach to decoding life: systems biology publication-title: Annu Rev Genomics Hum Genet doi: 10.1146/annurev.genom.2.1.343 – volume: 235 start-page: 411 issue: 4 year: 2010 ident: 2020080807562744800_bby043-B27 article-title: Current trends in mathematical modeling of tumor-microenvironment interactions: a survey of tools and applications publication-title: Exp Biol Med doi: 10.1258/ebm.2009.009230 – volume: 8 start-page: e1002742. issue: 10 year: 2012 ident: 2020080807562744800_bby043-B24 article-title: Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1002742 – volume: 75 start-page: 244 year: 2017 ident: 2020080807562744800_bby043-B48 article-title: Longitudinal effects of Parathyroid Hormone treatment on morphological, densitometric and mechanical properties of mouse tibia publication-title: J Mech Behav Biomed Mater doi: 10.1016/j.jmbbm.2017.07.034 – volume: 8 start-page: 175 issue: 4 year: 2003 ident: 2020080807562744800_bby043-B16 article-title: Advancing drug discovery through systems biology publication-title: Drug Discov Today doi: 10.1016/S1359-6446(03)02600-X |
| SSID | ssj0020781 |
| Score | 2.6129084 |
| SecondaryResourceType | review_article |
| Snippet | Abstract
Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is... Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow... |
| SourceID | proquest pubmed crossref oup |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1699 |
| SubjectTerms | Clinical trials Innovations Medical devices Medical equipment Modelling Patients Simulation Technological change |
| Title | In silico clinical trials: concepts and early adoptions |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29868882 https://www.proquest.com/docview/2955280845 https://www.proquest.com/docview/2050481609 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSwMxEA5SELyIb6u1RPTiITTNY7PxJmKpgnppobclr4VC2YrbHvrvTTa7C8Wi550lMJMw3zDzfQPAveBMKZwQlDPMEOPWIWUThnKVUp_eqRIi8J3fP5LxlL3N-Kweoil3tPAlHei5Hmi9wSxoevrsGxTyJ5-ztqwKcjWRQyRQEHdvREi3ft1KO1tUtl-IssosoyNwWENC-BRjeAz2XHEC9uOSyM0pEK8FLOcLHzHY0BhhtWujfIQmkg5LqAoLXdAqhsou45zKGZiOXibPY1SvO0CGMr5CRAitlMuZdVyllhOVc5caxzgeKuGhkDFDK7HR3FGXYBMorEwkvl4hWPmqg56DTrEs3CWAUgoP1IxJpQ1C5FQ7K7XKpbDaIy6Xd8FD443M1FrgYSXFIos9aZp5z2XRc11w19p-RQWMnVZ979Q_DXqNv7P6mZQZkZyTFKeMd8Ft-9lf8NC1UIVbrr0N5kHTJsGyCy5inNpjiEwTX8KTq_9OvwYHHulUw2FE9EBn9b12Nx5NrHS_ukw_wl7Fzw |
| linkProvider | Oxford University Press |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+silico+clinical+trials%3A+concepts+and+early+adoptions&rft.jtitle=Briefings+in+bioinformatics&rft.au=Pappalardo%2C+Francesco&rft.au=Russo%2C+Giulia&rft.au=Tshinanu%2C+Flora+Musuamba&rft.au=Viceconti%2C+Marco&rft.date=2019-09-27&rft.issn=1477-4054&rft.eissn=1477-4054&rft.volume=20&rft.issue=5&rft.spage=1699&rft_id=info:doi/10.1093%2Fbib%2Fbby043&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1467-5463&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1467-5463&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1467-5463&client=summon |